PPD - Decentralized Clinical Trials

PPD-Decentralized-Clinical-Trials.jpg

FULLY ENABLED DIGITAL TRANSFORMATION OF CLINICAL TRIALS

PPD pioneers digital capabilities and deploys solutions to streamline protocols, putting patient experience at the center of every design. Recently recognized by ISG as a leader in the design and deployment of decentralized clinical trial solutions, and patient engagement services, our teams can help you drive recruitment, engagement, retention and data quality.

Every day, customers choose us to digitally transform traditional study designs, ensure business continuity and advance lifesaving clinical research around the world.

  • Telemedicine
  • Direct-to/from-Patient Models
  • Remote eConsent
  • Home Health Care & Nursing
  • eCOA and ePRO
  • Mobile Sites
  • Remote Monitoring
  • Devices & Wearables
  • Regulatory Insights

Related Resources

Optimizing Adherence in DCTs

Optimizing Adherence in DCTs

Content provided by PPD - Decentralized Clinical Trials

White Paper

Prioritizing greater patient-centricity and creating an opportunity to reach unprecedented patient groups, decentralized and hybrid clinical trials are becoming more widely adopted.

PPD is Supporting Complex EU DCTs

PPD is Supporting Complex EU DCTs

Content provided by PPD - Decentralized Clinical Trials

White Paper

PPD supports European DCTs and clinical trial sponsors with a holistic and comprehensive approach

Helping Trial Sites Overcome Prevailing DCT Challenges

Helping Trial Sites Overcome Prevailing DCT Challenges

Content provided by PPD - Decentralized Clinical Trials

White Paper

As a CRO, PPD (part of Thermo Fisher) can help guide the future of clinical research. Its depth of experience with decentralized clinical trials (DCTs) — all over the world and of many design types — enables PPD to provide insight and feedback-based...